TAK438/Vonoprazan fumarate

Xi'an Huawave Biotech Co., Ltd. is a professional Vonoprazan fumarate TAK438 manufacturer and TAK438/Vonoprazan fumarate supplier . We are committed to providing customers with professional research and development, production and sales, as well as OEM and ODM processing services.
TAK438, also known as Takecab Tablets (Vonoprazan fumarate, TAK-438), is a novel type of gastric acid secretion inhibitor. Its primary efficacy lies in its potent and long-lasting inhibition of gastric acid secretion. Here are the details of its effects:

1. Mechanism of Action: Vonoprazan fumarate belongs to a new class of gastric acid secretion inhibitors called potassium (K+)-competitive acid blockers (P-CABs). It works by competitively blocking the binding of K+ to the H+-K+-ATP enzyme (proton pump) during the final step of gastric acid secretion in parietal cells, thereby terminating gastric acid secretion prematurely.
2. Rapid and Long-lasting Effect: Vonoprazan fumarate exhibits rapid onset of action, achieving maximum acid suppression on the first day of administration. Its inhibitory effect on gastric acid secretion is long-lasting and can persist for 24 hours.
3. Stable in Acidic Environment: Vonoprazan fumarate is stable in acid and can rapidly increase the pH value in the stomach, exerting its acid-suppressing effect.
4. Improvement in Night-time Acid Breakthrough: Vonoprazan fumarate has a certain improvement effect on night-time acid breakthrough, which is a common complication of proton pump inhibitor (PPI) therapy, characterized by a gastric pH value of less than 4 for more than 60 minutes during the night (from 10 pm to 8 am the next day), accompanied by symptoms such as burning sensation and acid regurgitation.
5. Broad Spectrum of Applications: In Japan, Vonoprazan fumarate has been approved for the treatment of gastric and duodenal ulcers, reflux esophagitis and its prevention of recurrence, secondary prevention of gastric mucosal damage induced by low-dose aspirin or non-steroidal anti-inflammatory drugs (NSAIDs), as well as for first- and second-line treatment for Helicobacter pylori eradication.
6. Good Tolerability and Safety: Vonoprazan fumarate has shown good tolerability and safety in clinical trials. However, it should be noted that long-term use may be associated with adverse reactions such as diarrhea, constipation, and an increased risk of fractures, especially in patients receiving high doses or long-term treatment (≥1 year).

In summary, Vonoprazan fumarate is an effective and safe gastric acid secretion inhibitor with a novel mechanism of action. It has a rapid onset of action, long-lasting inhibitory effect, and broad spectrum of applications, making it a valuable option for the treatment of various gastric acid-related diseases.

 TAK438/Vonoprazan fumarate, a potassium-competitive acid blocker (P-CAB), has a wide range of applications in medical treatment, primarily targeting gastric acid-related diseases. Here are the main uses of vonoprazan:

1. Treatment of Peptic Ulcers: Vonoprazan fumarate is effective in treating gastric and duodenal ulcers, including those caused by certain medications. It can relieve symptoms such as abdominal pain and discomfort, promote ulcer healing, and prevent ulcer recurrence.
2. Management of Reflux Esophagitis: Vonoprazan fumarate is also used to treat reflux esophagitis, a condition where stomach acid flows back into the esophagus, causing inflammation and damage. By inhibiting gastric acid secretion, Vonoprazan fumarate can reduce esophageal damage and alleviate symptoms such as heartburn and regurgitation.
3. Eradication of Helicobacter pylori: Vonoprazan fumarate can be combined with antibiotics to eradicate Helicobacter pylori, a bacterium that can cause peptic ulcers and other gastric diseases. The combination therapy can effectively eliminate the bacterium and reduce the recurrence rate of peptic ulcers.
4. Prevention of Gastric Mucosal Damage: Vonoprazan fumarate can prevent gastric mucosal damage caused by low-dose aspirin or non-steroidal anti-inflammatory drugs (NSAIDs). By inhibiting gastric acid secretion, it can reduce the risk of gastric ulcers and bleeding.

In summary, Vonoprazan fumarate is a versatile medication with multiple applications in the treatment of gastric acid-related diseases. It can relieve symptoms, promote healing, prevent recurrence, and improve patients' quality of life. However, as with any medication, it should be used under the guidance of a healthcare professional and in accordance with the prescribed dosage and duration.